Skip to content

NeuraNova Receives FDA 510(k) Clearance for STEDI Device

NeuraNova has received FDA 510(k) clearance for its STEDI device, marking its first FDA clearance. This approval allows the company to market the device, which is expected to enhance patient care or technology in its category.

LOS ANGELES–(BUSINESS WIRE)–NeuraNova Receives First FDA 510(k) Clearance